These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3228824)

  • 1. Anti-ischemic effects of slow-release formulations of nifedipine, isosorbide-5-mononitrate and their combination in patients with coronary heart disease.
    Erlemeier HH; Kupper W; Hempel NB; Bleifeld W
    Cardiology; 1988; 75(6):409-18. PubMed ID: 3228824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
    Erlemeier HH; Kupper W; Lange S; Bleifeld W
    Z Kardiol; 1986; 75 Suppl 3():112-4. PubMed ID: 3541415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM; Curry PV; Bailey AE; Steare SE
    Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy with slow release isosorbide nitrate and diltiazem in silent myocardial ischemia].
    Brisse B; Behrenbeck T; Ebert U; Navah R; Bender F
    Z Kardiol; 1989; 78 Suppl 2():175-8; discussion 188-9. PubMed ID: 2686257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris.
    von Arnim T; Erath A; Reuschel-Janetschek E
    Eur Heart J; 1988 Jan; 9 Suppl A():113-8. PubMed ID: 3409907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion.
    Stegaru B; Loose R; Keller H; Buss J; Wetzel E
    Am J Cardiol; 1988 Mar; 61(9):74E-77E. PubMed ID: 3348141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris.
    de Vries RJ; Dunselman PH; van Veldhuisen DJ; van den Heuvel AF; Wielenga RP; Lie KI
    Am J Cardiol; 1994 Dec; 74(12):1201-6. PubMed ID: 7977090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long term therapy of coronary heart disease with 120 mg slow release isosorbide dinitrate once a day. Study of duration of action and development of tolerance].
    Ohlmeier H; Mertens HM; Möller M; Mannebach H; Gleichmann U
    Z Kardiol; 1986; 75 Suppl 3():50-6. PubMed ID: 3541419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
    Rettig GF; Jakob M; Koch HP
    Z Kardiol; 1992 Oct; 81(10):525-30. PubMed ID: 1441691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A; Meshulam R; Schlesinger Z
    Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-effect relationship amongst three different sustained-release forms of isosorbide 5-mononitrate in patients with coronary artery disease.
    Kenedi P; Gathmann-Lewik U
    Cardiology; 1987; 74 Suppl 1():29-33. PubMed ID: 3300975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
    Yasky J; Ontanilla E; Koch JE
    Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.